Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Clinical trial NCT00811785 · COMPLETED
Trial details
- NCT number
- NCT00811785
- Sponsor
- Cyprium Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-27
- Primary completion
- 2020-08-28
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.